115 related articles for article (PubMed ID: 15083771)
1. Diagnostic implications of telomerase activity in pleural effusions.
Garcia-Pachon E; Padilla-Navas I
Eur Respir J; 2004 Apr; 23(4):653-4. PubMed ID: 15083771
[No Abstract] [Full Text] [Related]
2. Telomerase activity in pleural effusions: diagnostic significance.
Yang CT; Lee MH; Lan RS; Chen JK
J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic implications of telomerase activity in pleural effusions.
Dikmen G; Dikmen E; Kara M; Sahin E; Doğan P; Ozdemir N
Eur Respir J; 2003 Sep; 22(3):422-6. PubMed ID: 14516130
[TBL] [Abstract][Full Text] [Related]
4. [Potential role of cholesterol in distinguishing malignant from benign pleural effusion].
Plavec G; Tomić I; Nidzović N; Radojcić B; Aćimović S; Bokun R
Vojnosanit Pregl; 2004; 61(6):607-11. PubMed ID: 15717721
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
Kuralay F; Tokgöz Z; Cömlekci A
Clin Chim Acta; 2000 Oct; 300(1-2):43-55. PubMed ID: 10958862
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion].
Li H; Fu J; Xiu Y; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):652-4. PubMed ID: 20681457
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions].
Yang Z; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):201-3. PubMed ID: 11802962
[TBL] [Abstract][Full Text] [Related]
8. Evaluating diagnostic tests in the pleural space. Differentiating transudates from exudates as a model.
Heffner JE
Clin Chest Med; 1998 Jun; 19(2):277-93. PubMed ID: 9646981
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
10. Different expression of FoxM1 in human benign and malignant pleural effusion.
Tang Z; Li H; Zhu H; Bai C
Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
[TBL] [Abstract][Full Text] [Related]
11. Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures.
Alemán C; Sanchez L; Alegre J; Ruiz E; Vázquez A; Soriano T; Sarrapio J; Teixidor J; Andreu J; Felip E; Armadans L; Fernández De Sevilla T
QJM; 2007 Jun; 100(6):351-9. PubMed ID: 17525131
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of suPAR in differentiating noncardiac pleural effusions from cardiac pleural effusions.
Ozsu S; Oztuna F; Mentese A; Abul Y; Ozlu T
Clin Respir J; 2016 Jan; 10(1):61-6. PubMed ID: 25043397
[TBL] [Abstract][Full Text] [Related]
13. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
Lee WY
Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of pleural effusion by lactate dehydrogenase isoenzyme analysis.
Lossos IS; Breuer R; Intrator O; Sonenblick M
Chest; 1997 Mar; 111(3):648-51. PubMed ID: 9118702
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
[TBL] [Abstract][Full Text] [Related]
16. Screening of malignant pleural effusion by discriminant analysis.
Carrión-Valero F; Perpiñá-Tordera M; Sanchis-Aldás J
Int J Tuberc Lung Dis; 2003 Sep; 7(9):892-8. PubMed ID: 12971675
[TBL] [Abstract][Full Text] [Related]
17. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
[TBL] [Abstract][Full Text] [Related]
18. Tumor markers in undiagnosed pleural effusions.
Light RW
Chest; 2004 Dec; 126(6):1721-2. PubMed ID: 15596661
[No Abstract] [Full Text] [Related]
19. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
20. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]